Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

308 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Switching from natalizumab administration at the day hospital to administration at home. A 1 year prospective study of patient experience and quality of life in 30 consecutive patients with multiple sclerosis (TYSAD-35).
Lamy S, Veillard D, Doyen H, Kerbrat A, Michel L, Chretien E, Ousmen A, Edan G, Le Page E. Lamy S, et al. Among authors: edan g. Mult Scler Relat Disord. 2023 May;73:104657. doi: 10.1016/j.msard.2023.104657. Epub 2023 Mar 23. Mult Scler Relat Disord. 2023. PMID: 37001411 Free PMC article.
[Drug therapy in multiple sclerosis].
Le Page E, Edan G. Le Page E, et al. Among authors: edan g. Rev Prat. 2006 Jun 30;56(12):1336-46. Rev Prat. 2006. PMID: 16948222 Review. French.
Mitoxantrone as induction treatment in aggressive relapsing remitting multiple sclerosis: treatment response factors in a 5 year follow-up observational study of 100 consecutive patients.
Le Page E, Leray E, Taurin G, Coustans M, Chaperon J, Morrissey SP, Edan G. Le Page E, et al. Among authors: edan g. J Neurol Neurosurg Psychiatry. 2008 Jan;79(1):52-6. doi: 10.1136/jnnp.2007.124958. Epub 2007 Sep 10. J Neurol Neurosurg Psychiatry. 2008. PMID: 17846110 Clinical Trial.
Switching from natalizumab to fingolimod in multiple sclerosis: a French prospective study.
Cohen M, Maillart E, Tourbah A, De Sèze J, Vukusic S, Brassat D, Anne O, Wiertlewski S, Camu W, Courtois S, Ruet A, Debouverie M, Le Page E, Casez O, Heinzlef O, Stankoff B, Bourre B, Castelnovo G, Rico A, Berger E, Camdessanche JP, Defer G, Clavelou P, Al Khedr A, Zephir H, Fromont A, Papeix C, Brochet B, Pelletier J, Lebrun C; Club Francophone de la Sclérose en Plaques Investigators. Cohen M, et al. JAMA Neurol. 2014 Apr;71(4):436-41. doi: 10.1001/jamaneurol.2013.6240. JAMA Neurol. 2014. PMID: 24566807 Clinical Trial.
308 results